Helena Eixarch is a cosmetics and toxicology consultant providing regulatory support with all aspects of cosmetic products regulatory compliance. Before becoming a consultant, Helena gained experience as a regulatory toxicologist directly from the industry. Helena has a degree and a PhD in Biochemistry. She holds a Diploma on Cosmetic Products Safety Assessment and is a European Registered Toxicologist. ABOUT THE AUTHOR REGULATION “responsible person” shall be placed on the market. Manufacturers, importers or distributors may become responsible persons. 2. According toArticle 13 of theRegulation, prior to placing the cosmetic product on themarket the RP shall submit, by electronicmeans, a list of detailed information on the cosmetic product to the Commission. 3. Adverse reactions for human health attributable to the normal or reasonably foreseeable use of a cosmetic product resulting in temporary or permanent functional incapacity, disability, hospitalisation,congenitalanomaliesoranimmediatevitalriskordeath. BIBLIOGRAPHY AND WEB REFERENCES 1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. OJ L 342, 22.12.2009, p. 59. 2. Commission Regulation (EU) No 655/2013 of 10 July 2013 laying down common criteria for the justification of claims used in relation to cosmetic products. Official Journal of the European Union L 190/31, 11.7.2013. Nevertheless, important safety issuesmay arisewhenmixingactives or boosters with base creams from different brands. Anticipation of the finished product’s characteristics is not possible, and a safety assessment and CPNP notification cannot be performed: the resulting product is non-compliant and more importantly, may have associated safety issues. Finally, in the case of a SUE, it is difficult to determinewhat actually caused theadverseeffect (thebooster or the base cream) and, therefore, responsibilities are not clearly defined. Therefore, if boosters are to be marketed, they should be prescribed for their use only with bases manufactured by the same brand, to avoid non-compliance and safety issues. SUMMARY AND CONCLUSION Marketing personalised products can be challenging from a regulatory point of view, and only those products for which compliance is achievable should be placed on the market. Of all the discussed possibilities, the most compliant options are online purchase and the use of domestic devices, which allow a higher degree of control over product composition and the timely performance of safety assessment and product notification. On the contrary, on-site manufacturing (at the retail store) poses higher compliance and safety challenges and use of boosters is only encouraged if it can be ensured that all products to bemixed will be manufactured by the same brand. REFERENCES AND NOTES 1. As stated in the Regulation, only cosmetic products for which a legal or natural person is designated within the Community as HOME FRAGRANCE: PIVOTING WITH DIGITAL SAVES MARKET Following a year of respectable performance in 2019 with 4.2% sales gains, the U.S. home fragrances market is poised to end the year with flat growth, which is considered an outstanding result in these uncertain times. Home scent products, notably candles, have become a category of comfort and escapism for housebound consumers in 2020, moving from a desirable purchase to a quarantine essential. Despite a significant number of non-essential store closures in March and April— more than 15,000 brick-and-mortar locations selling home fragrances shuttered doors for a fewmonths during the onset of the pandemic—strong demand for home fragrance products during COVID-19 are predicted to prevent declines in this market in 2020. This is because marketers have been able to shift gears quickly and respond with positive initiatives: - Luxury and specialty brands are prioritizing digital. Store closures of non-essential retail have forced luxury and specialty players to lean on e-commerce and digital platforms. Lafco introduced a digital programto support its local retailer partners that were forced to shutter doors. Meanwhile, newcomer CancelledPlans, which launched in 2019 and sells through its own e-commerce platform, has gained tractionwith its brand name that appeals to consumers in quarantine. The brand’smost recent launchwas a candle called “I MissHigh Fives.” - The market has seen new entrants amid the pandemic. Several new brands have entered the market during COVID-19, and niche indie players have gained momentum, benefiting from the positive traction that candles have seen this year. Sephora introduced a line of candles under its private-label line, Sephora Collection, and Elle West, a new brand based in Los Angeles, launched online in June. - New categories are on the horizon. Brands that cross categories, like Bath & Body Works, are seeing traction with their ancillary items like hand sanitizers and body lotions. This continues to be a theme in the market, as NEST recently debuted its kitchen collection, featuring all-purpose cleaners and dish soaps. Meanwhile, several newcomers to the market are slated to enter personal care and body care categories by the end of the year. While the forecast is stable for candles and other home scent products, uncertainty still exists as the rising number of coronavirus cases in the United States could result in re-closures of non-essential retailers in the short term. To learn more about key trends and dynamics that shaped the market in 2019 and what’s ahead for the remainder of 2020 and 2021 as home fragrance marketers navigate the current retail environment, please refer to our annual Home Fragrances USA report.